Navigation Links
Size really does not matter when it comes to high blood pressure
Date:9/3/2013

Removing one of the tiniest organs in the body has shown to provide effective treatment for high blood pressure. The discovery, made by University of Bristol researchers and published in Nature Communications, could revolutionise treatment of the world's biggest silent killer.

The carotid body a small nodule (no larger than a rice grain) found on the side of each carotid artery appears to be a major culprit in the development and regulation of high blood pressure.

Researchers, led by British Heart Foundation (BHF)-funded researcher Professor Julian Paton, found that by removing the carotid body connection to the brain in rodents with high blood pressure, blood pressure fell and remained low.

Professor Paton, from Bristol's School of Physiology and Pharmacology, said: "We knew that these tiny organs behaved differently in conditions of hypertension but had absolutely no idea that they contributed so massively to the generation of high blood pressure; this is really most exciting."

Normally, the carotid body acts to regulate the amount of oxygen and carbon-dioxide in the blood. They are stimulated when oxygen levels fall in your blood as occurs when you hold your breath. This causes a dramatic increase in breathing and blood pressure until blood oxygen levels are restored. This response comes about through a nervous connection between the carotid body and the brain.

Professor Paton commented: "Despite its small size the carotid body has the highest blood flow of any organ in the body. Its influence on blood pressure likely reflects the priority of protecting the brain with enough blood flow."

The team's work on carotid body research started in the late 1990's and their recent discovery has since led to a human clinical trial at the Bristol Heart Institute of which the results are expected at the end of the year.

Professor Paton added: "This is an extremely proud moment for my research team as it is rare that this type of research can so quickly fuel a human clinical trial. I am delighted that Bristol was chosen as a site for this important trial."

Professor Jeremy Pearson, Associate Medical Director at the BHF, which part-funded the research, said: "For around one in fifty people with high blood pressure, taking pills does not help their condition. This research, in rats, has found that blocking special nerve endings in the neck significantly reduces blood pressure.

"This breakthrough has already kicked-off a small trial to find out whether this treatment is safe and effective in people with high blood pressure resistant to medication. This potential new treatment has real promise to help this hard-to-treat group of patients."


'/>"/>

Contact: Caroline Clancy
caroline.clancy@bristol.ac.uk
44-011-792-88086
University of Bristol
Source:Eurekalert

Related biology news :

1. Which Prostate Cancers Really Need Treatment?
2. Genomic data are growing, but what do we really know?
3. Deodorants: Do we really need them?
4. Thermodynamics really from scratch -- in a new textbook
5. What is really causing the child obesity epidemic?
6. Are we really a nation of animal lovers?
7. Family matters: Evolutionary relationships among species of magic mushrooms shed light on fungi
8. Learning to recycle: Does political ideology matter?
9. Cat and mouse: A single gene matters
10. Age matters to Antarctic clams
11. Study: Environmental policies matter for growing megacities
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/20/2016)... A market that just keeps on growing. Molecular Diagnostics ... genomics knowledge. Learn all about it in this new ... trends are pushing market growth and company valuations. Trends ... pathogen evolution - next generation sequencing - emergence of ... the role of genetic material in Disease and Health ...
(Date:1/13/2016)... ALBANY, New York , January 13, 2016 /PRNewswire/ ... Transparency Market Research has published a new market report ... Share, Growth, Trends, and Forecast, 2015 - 2023. According to ... mn in 2014 and is anticipated to reach US$1,625.8 ... from 2015 to 2023. In terms of volume, the ...
(Date:1/8/2016)... January 8, 2016 NXTD ), ... WorldVentures ® , a privately held leading direct seller ... Inc. 5000 fastest-growing company announced that on December ... $2 million in Nxt-ID to develop a proprietary new ... Wocket ® , a unique smart wallet that serves ...
Breaking Biology News(10 mins):
(Date:2/5/2016)... Feb. 5, 2016 Australian-US drug discovery and development ... the appointment of a new Chairman, Mr John O,Connor ... effective immediately. James Garner , has also ... and former Acting CEO, Mr Iain Ross , will ... --> James Garner , has also been formally ...
(Date:2/4/2016)... ... February 04, 2016 , ... ... takes place February 5-6 at the University’s student center, Kehr Union, located ... as workshops and competitions for ample networking, learning and collaborating opportunities. , ...
(Date:2/4/2016)... N.J. , Feb. 4, 2016 ContraVir ... focused on the development and commercialization of targeted antiviral ... CEO & Investor Conference 2016, to be held February ... Source Capital Group,s 2016 Disruptive Growth & Healthcare Conference, ... on February 10-11, 2016. James Sapirstein , ...
(Date:2/4/2016)... NY (PRWEB) , ... February 04, 2016 , ... Many ... for over 10 years. What sets them apart from other cuvette manufacturers ... is posted on their website. On top of this steady flow of inside ...
Breaking Biology Technology: